by Namrata Sen | Apr 20, 2026 | General
Shares of Enveric BioSciences (NASDAQ:ENVB) added over 92% in the premarket trading session on Monday. AtaiBeckley Inc (NASDAQ:ATAI) surged by 28.1%, while Compass Pathways (NASDAQ:CMPS) and Definium Therapeutics (NASDAQ:DFTX) saw their shares ascend by 26.1% and...
by Tanya Rawat | Apr 20, 2026 | General
The economic fallout from the U.S.-Iran war is proving more stubborn than the conflict itself, with economists warning that a wave of inflation will persist long after the fighting stops, the Financial Times reported Sunday. Prices Already Climbing U.S. inflation...
by Avi Kapoor | Apr 20, 2026 | General
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. BMO Capital analyst Keith Bachman initiated coverage on Kyndryl...
by Akanksha Bakshi | Apr 20, 2026 | General
Accenture Plc (NYSE:ACN) shares edged higher in Monday’s premarket session after the company introduced new manufacturing-focused AI capabilities with partners. Agentic Factory System Unveiled Accenture and Avanade, alongside Microsoft Corp (NASDAQ:MSFT),...
by Parshwa Turakhiya | Apr 20, 2026 | General
Ethereum (CRYPTO: ETH) ETFs recorded $276 million in net inflows last week, yet prominent crypto trader Ansem warns the $300 billion asset could target $1,300 if the downtrend continues. The Bear Case Building Ansem laid out a multi-pronged case against Ethereum....
Recent Comments